Clinical trial
A Prospective, Multicenter, Postmarket Study of Sebacia Microparticles Treatment in Patients Using Topical Acne Products for Mild to Moderate Inflammatory Acne Vulgaris
NCT03818555 is registered in ClinicalTrials.gov with Sebacia, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Postmarket Study of Sebacia Microparticles Treatment in Patients Using Topical Acne Products for Mild to Moderate Inflammatory Acne Vulgaris
- Lead sponsor
- Sebacia, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- June 30, 2021
- Enrollment
- 125 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.